innovations during the drug
discovery phase.
We take a personalized and integrated approach to help our clients position their pipelines and companies for success offering a full range of development and commercialization services.
We are Halloran, a life science consulting firm, partnering to enrich your product development and business growth. We propel your organization further; positively impacting the health and wellbeing of patients around the world.
Halloran was proud to sponsor Foundation NYC, an annual event for entrepreneurs and investors in the Biomedical space – specifically those based in New York City and its nearby areas. With about 80 attendees, most from biomedical startups, Consultant Anmol Grover moderated the panel discussion, “A Deal Grows in Midtown: How BI’s Foray into NYC led to a transaction with BioHarmony Tx.”
Panelists included Dr. Chandra Ghose, CEO, BioHarmony Therapeutics and Dr. Junjun Gao, Senior Director of External Innovation, Boehringer Ingelheim. The discussion centered on pre-diligence, diligence activities performed by BI, strategic engagements from BioHarmony to attract investors, best practices for entering into a deal, and how to be an effective start-up CEO. Talks also focused on the state of entrepreneurship in New York City, and the associated challenges.